MOHS surgery in Israel offers two major advantages:
- Tissue preservation: By immediately examining the surgical margins during the procedure, surgeons can avoid unnecessary wide excisions. This allows for precise removal of cancerous tissue while conserving as much healthy tissue as possible, resulting in better aesthetic and functional outcomes.
- High cure rates: MOHS surgery achieves cure rates of 96% to 99% — the highest among all skin cancer treatment methods — thanks to thorough examination of 100% of the surgical margins and the ability to continue resection until clear margins are confirmed.
MOHS skin cancer surgery in Israel is considered the gold standard for removing skin cancer, especially in cosmetically and functionally critical areas such as the face, neck, hands, feet, and genitals. It is also recommended for recurrent tumors and high-risk lesions.
Outpatient Procedure
Most MOHS and dermatologic surgery in Israel is performed on an outpatient basis under local anesthesia. Patients are usually admitted in the morning and discharged the same day. There is no need for special preparation or fasting.
Suspicious skin lesions, non-healing wounds, and moles that have changed in color, shape, or size are examined and, if necessary, removed. The excised tissue is sent for histological analysis, with results typically available within 2–3 weeks.
After tumor removal, the resulting wound is closed using advanced techniques to ensure the best possible cosmetic result. Skin grafts may be used if needed. Israel’s dermatologic oncology and plastic surgery specialists at Ichilov are highly experienced in skin reconstruction, ensuring natural-looking results.
